Fortrea Holdings Inc. (NASDAQ:FTRE – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $19.20, but opened at $20.25. Fortrea shares last traded at $20.6360, with a volume of 217,928 shares trading hands.
Key Headlines Impacting Fortrea
Here are the key news stories impacting Fortrea this week:
- Positive Sentiment: Fortrea reported second-quarter adjusted earnings of $0.23 per share, above the $0.18 analyst consensus and up from $0.19 a year earlier. Revenue reached $678.2 million, exceeding estimates of $647.6 million. Fortrea Surpasses Q2 Earnings and Revenue Estimates
- Positive Sentiment: The contract research organization raised or increased its full-year outlook and forecast 2026 revenue of $2.62 billion to $2.69 billion. Management highlighted four consecutive quarters of operational, commercial and financial execution, supporting the view that demand and business performance are improving. Fortrea Reports Second Quarter 2026 Results
- Neutral Sentiment: Management’s earnings call emphasized strong revenue guidance and continued execution, but investors will likely watch whether the improved outlook translates into sustained profitability. Fortrea still carries a negative net margin, making guidance credibility particularly important. Fortrea Q2 2026 Earnings Call Highlights
- Negative Sentiment: Fortrea appointed director David Smith as interim chief financial officer while CFO-related matters remain unsettled. The appointment comes amid an ongoing legal dispute involving former CFO Michael Madlock and a covenant proceeding, creating governance, legal and execution concerns that may be weighing on the shares. Fortrea Forecasts Revenue and Names Interim CFO
Wall Street Analysts Forecast Growth
Several analysts have commented on FTRE shares. Robert W. Baird set a $20.00 price target on shares of Fortrea in a research note on Wednesday, May 6th. Citigroup lifted their target price on Fortrea from $16.00 to $20.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Zacks Research upgraded Fortrea from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Evercore reissued an “outperform” rating on shares of Fortrea in a research note on Wednesday. Finally, Wall Street Zen cut Fortrea from a “buy” rating to a “hold” rating in a report on Tuesday, July 21st. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $17.75.
Fortrea Price Performance
The company has a market capitalization of $1.93 billion, a PE ratio of -4.15, a price-to-earnings-growth ratio of 0.63 and a beta of 2.03. The company has a quick ratio of 0.95, a current ratio of 0.95 and a debt-to-equity ratio of 1.98. The firm’s 50 day simple moving average is $16.81 and its 200 day simple moving average is $13.79.
Fortrea (NASDAQ:FTRE – Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $0.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.05. Fortrea had a negative net margin of 16.50% and a positive return on equity of 9.51%. The firm had revenue of $678.20 million during the quarter, compared to analyst estimates of $647.57 million. As a group, research analysts anticipate that Fortrea Holdings Inc. will post 0.8 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the business. Assenagon Asset Management S.A. raised its holdings in shares of Fortrea by 90.7% in the second quarter. Assenagon Asset Management S.A. now owns 173,129 shares of the company’s stock worth $3,012,000 after buying an additional 82,349 shares during the period. Essential Partners LLC grew its position in Fortrea by 140.2% in the 1st quarter. Essential Partners LLC now owns 9,675 shares of the company’s stock valued at $91,000 after acquiring an additional 5,647 shares during the last quarter. Amundi grew its position in Fortrea by 20.2% in the 1st quarter. Amundi now owns 12,490 shares of the company’s stock valued at $118,000 after acquiring an additional 2,101 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in Fortrea by 9.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 10,936 shares of the company’s stock worth $103,000 after buying an additional 953 shares during the period. Finally, California State Teachers Retirement System lifted its holdings in Fortrea by 51.3% during the 1st quarter. California State Teachers Retirement System now owns 132,369 shares of the company’s stock valued at $1,247,000 after buying an additional 44,882 shares in the last quarter.
About Fortrea
Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific’s Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company’s comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.
Fortrea’s core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.
Read More
- Five stocks we like better than Fortrea
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Fortrea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortrea and related companies with MarketBeat.com's FREE daily email newsletter.
